
New Commercial Capabilities for a New Era
Improving In-Field Performance with Training Insight

Omnichannel Education For The Life Sciences

New Era; New Launch Excellence Blueprint for 2021-2022

The Triple A Initiative: ACTO, Axiom, and AstraZeneca

The Triple A Initiative: ACTO, Axiom, and AstraZeneca

New Era; New Launch Excellence Blueprint for 2021-2022

Episode 8: Omnichannel Education – The Future of Life Sciences

Episode 7: How is Technology Reshaping the Medical Device Industry?

Episode 6: Pharma Sales – Today versus Tomorrow

Special Episode: Two Powerhouses Come Together: ACTO acquires Scrimmage

Episode 4: Agile Change Management for Life Sciences Leaders

Episode 1: Tailoring Your Clinical and Brand Story with Integrity
